Ken Takanashi
Director · Wave Life Sciences, Inc.
- 2025
- Oct 8, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ken Takanashi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $54.63M in WVE purchases and sales in the last 12 months
- Chris Francis - $7.10M in WVE purchases and sales in the last 12 months
- Kyle Moran - $4.15M in WVE purchases and sales in the last 12 months
- Aik Na Tan - $1.83M in WVE purchases and sales in the last 12 months
- Christian O. Henry - $1.37M in WVE purchases and sales in the last 12 months
- Adrian Rawcliffe - $807K in WVE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ken Takanashi?
Ken Takanashi is a corporate insider, tracked as Director of Wave Life Sciences, Inc. (WVE). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ken Takanashi submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Ken Takanashi been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($66K) across all tracked filings.